Stock PEREGRINE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Peregrine Pharmaceuticals Nasdaq

Equities

US7136615025

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
Avid Bioservices to Participate at Upcoming Investor Conferences
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating
MT
Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024
Avid Bioservices: Fiscal Q3 Earnings Snapshot
AQ
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
AQ
Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
North American Morning Briefing : Stock Futures -2-
DJ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited
DJ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
North American Morning Briefing : Stocks Struggle After New Records
DJ
Avid Bioservices Receives Nasdaq Noncompliance Notice
MT
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
AQ
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood
DJ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
BU
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDMO Stock
  4. Stock
  5. News Peregrine Pharmaceuticals